» Articles » PMID: 30252420

Anemia in Older Adults

Overview
Specialty Public Health
Date 2018 Sep 26
PMID 30252420
Citations 48
Authors
Affiliations
Soon will be listed here.
Abstract

Anemia is associated with increased morbidity and mortality in older adults. Diagnostic cutoff values for defining anemia vary with age, sex, and possibly race. Anemia is often asymptomatic and discovered incidentally on laboratory testing. Patients may present with symptoms related to associated conditions, such as blood loss, or related to decreased oxygen-carrying capacity, such as weakness, fatigue, and shortness of breath. Causes of anemia in older adults include nutritional deficiency, chronic kidney disease, chronic inflammation, and occult blood loss from gastrointestinal malignancy, although in many patients the etiology is unknown. The evaluation includes a detailed history and physical examination, assessment of risk factors for underlying conditions, and assessment of mean corpuscular volume. A serum ferritin level should be obtained for patients with normocytic or microcytic anemia. A low serum ferritin level in a patient with normocytic or microcytic anemia is associated with iron deficiency anemia. In older patients with suspected iron deficiency anemia, endoscopy is warranted to evaluate for gastrointestinal malignancy. Patients with an elevated serum ferritin level or macrocytic anemia should be evaluated for underlying conditions, including vitamin B12 or folate deficiency, myelodysplastic syndrome, and malignancy. Treatment is directed at the underlying cause. Symptomatic patients with serum hemoglobin levels of 8 g per dL or less may require blood transfusion. Patients with suspected iron deficiency anemia should be given a trial of oral iron replacement. Lower-dose formulations may be as effective and have a lower risk of adverse effects. Normalization of hemoglobin typically occurs by eight weeks after treatment in most patients. Parenteral iron infusion is reserved for patients who have not responded to or cannot tolerate oral iron therapy.

Citing Articles

In-hospital stay of anemic patients in the ED with/without transfusion: a single-center propensity-matched study.

Coisy F, Anselme C, Goulabchand R, Grau-Mercier L, Markarian T, Bobbia X BMC Emerg Med. 2025; 25(1):29.

PMID: 39988701 PMC: 11849158. DOI: 10.1186/s12873-025-01187-y.


Macrocytic anemia, kidney dysfunction, and mortality in general population: Japan specific health checkup study.

Otaki Y, Watanabe T, Konta T, Watanabe M, Asahi K, Yamagata K Sci Rep. 2024; 14(1):32005.

PMID: 39738456 PMC: 11686307. DOI: 10.1038/s41598-024-83547-5.


Association of hemoglobin levels with cause-specific and all-cause mortality among older adults: a prospective cohort study.

Ni W, Yuan X, Zhang Y, Zhang H, Zheng Y, Xu J Front Public Health. 2024; 12:1435283.

PMID: 39624407 PMC: 11609071. DOI: 10.3389/fpubh.2024.1435283.


A Nomogram for Predicting the Effectiveness of Consultations on Multi-Drug Resistant Infections: An Exploration for Clinical Pharmacy Services.

Ao H, Song H, Li J Infect Drug Resist. 2024; 17:3439-3450.

PMID: 39139627 PMC: 11319096. DOI: 10.2147/IDR.S470883.


Predictive value of the early postoperative hemoglobin-to-red blood cell distribution width ratio for acute kidney injury in elderly intertrochanteric fracture patients.

Yuan X, Zeng W, Wang H, Shu G, Wu C, Nie M BMC Musculoskelet Disord. 2024; 25(1):630.

PMID: 39113005 PMC: 11308471. DOI: 10.1186/s12891-024-07745-y.